AJP - Lung Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol 272: L413-L417, 1997;
1040-0605/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adamson, I. Y.
Right arrow Articles by Bakowska, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adamson, I. Y.
Right arrow Articles by Bakowska, J.

AJP - Lung Cellular and Molecular Physiology, Vol 272, Issue 3 413-L417, Copyright © 1997 by American Physiological Society

ARTICLES

Enhanced alveolar type II cell growth on a pulmonary extracellular matrix over fibroblasts

I. Y. Adamson, L. Young and J. Bakowska
Department of Pathology, University of Manitoba, Winnipeg, Canada.

The growth of alveolar type II cells was studied when these cells were maintained for 2 days on a pulmonary endothelium-derived extracellular matrix (ECM) on a filter with or without lung fibroblasts in the lower chambers of culture wells. Type II cell proliferation was enhanced by the ECM compared with other substrates but was significantly higher with fibroblasts beneath. This was determined by thymidine uptake and cell numbers. The diffusing factor from fibroblasts appeared to be keratinocyte growth factor (KGF), because this cytokine increased type II cell growth in culture and the neutralizing antibody to KGF blocked the observed fibroblast-induced growth increase. None of the antibodies to various cytokines had any effect on the ECM-induced proliferation. Although the type II cells were shown to produce degradative activity for the ECM, there was little secreted enzyme activity in supernatants and there was no demonstrated autocrine-regulated growth effect. The results suggest that type II cell growth may be stimulated by both 1) a matrix-bound factor that acts through a cell contact-mediated process, and 2) a fibroblast-secreted factor that appears to be KGF.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. A. Olman and M. A. Matthay
Transforming growth factor-{beta} induces fibrosis in immune cell-depleted lungs
Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L522 - L526.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. H. Michelson, M. Tigue, R. J. Panos, and P. H. S. Sporn
Keratinocyte growth factor stimulates bronchial epithelial cell proliferation in vitro and in vivo
Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L737 - L742.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. Y. R. Adamson and J. Bakowska
Relationship of Keratinocyte Growth Factor and Hepatocyte Growth Factor Levels in Rat Lung Lavage Fluid to Epithelial Cell Regeneration after Bleomycin
Am. J. Pathol., September 1, 1999; 155(3): 949 - 954.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online